Gerard Brophy Insider Trading $AVTR Avantor, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gerard Brophy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gerard Brophy. Gerard Brophy is EVP, Biopharma Production in Avantor, Inc. ($AVTR).
Gerard Brophy in Avantor, Inc.
Trading Symbol: AVTRIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Gerard Brophy: EVP, Biopharma Production
Holdings: 168,982 shares
Latest Transaction: May 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Gerard Brophy in Avantor, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 30.90 | 19,683 | 608,205 | 168,982 | 188.7 K to 169 K (-10.43 %) |
Feb 26 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.93 | 3,059 | 85,438 | 172,384 | 175.4 K to 172.4 K (-1.74 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 17.67 | 19,769 | 349,318 | 59,306 | |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 28.62 | 19,769 | 565,789 | 175,443 | 195.2 K to 175.4 K (-10.13 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 17.67 | 19,769 | 349,318 | 195,212 | 175.4 K to 195.2 K (+11.27 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 28.69 | 3,072 | 88,136 | 175,443 | 178.5 K to 175.4 K (-1.72 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 23.21 | 162,248 | 3,765,776 | 162,250 | |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 30.04 | 162,248 | 4,873,930 | 178,515 | 340.8 K to 178.5 K (-47.61 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 23.20 | 162,248 | 3,764,154 | 340,763 | 178.5 K to 340.8 K (+90.89 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 30.08 | 216,332 | 6,507,267 | 178,515 | 394.8 K to 178.5 K (-54.79 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 23.20 | 216,332 | 5,018,902 | 394,847 | 178.5 K to 394.8 K (+121.18 %) |
Jan 08 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.24 | 11,509 | 313,505 | 178,515 | 190 K to 178.5 K (-6.06 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 18.45 | 59,418 | 1,096,262 | 118,835 | |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.84 | 59,418 | 1,654,197 | 190,024 | 249.4 K to 190 K (-23.82 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 18.45 | 59,418 | 1,096,262 | 249,442 | 190 K to 249.4 K (+31.27 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 28.15 | 6,559 | 184,636 | 190,024 | 196.6 K to 190 K (-3.34 %) |
May 22 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 17.36 | 25,495 | 442,593 | 196,583 | 222.1 K to 196.6 K (-11.48 %) |
May 19 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 17.86 | 13,790 | 246,289 | 222,078 | 235.9 K to 222.1 K (-5.85 %) |
Feb 25 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | A | 17.67 | 79,075 | 1,397,255 | 79,075 | |
Feb 25 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Grant | A | 0.00 | 24,524 | 0 | 235,868 | 211.3 K to 235.9 K (+11.60 %) |
Jan 06 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | A | 18.45 | 178,253 | 3,288,768 | 178,253 | |
Jan 06 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Grant | A | 0.00 | 54,201 | 0 | 211,344 | 157.1 K to 211.3 K (+34.49 %) |
May 23 2019 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Grant | A | 0.00 | 157,143 | 0 | 157,143 | 0 to 157.1 K |
Page: 1